Sex- and Context-dependent Effects of Oxytocin on Social Reward Processing

University of Electronic Science and Technology of China

Status: Unknown

Conditions: Mental Health Wellness 1; Social Behavior; Emotion

Treatments: Drug: Placebo; Drug: Oxytocin

Study type: Interventional

Funder types: Other

Identifiers

NCT03085628

UESTC-neuSCAN-08

Details and patient eligibility

About

The aim of the present study is to examine whether the neuropeptide oxytocin (OXT) influences social reward processing and whether the effects are context- and sex-dependent.

Full description

In a double-blind, randomized, placebo-controlled, between-subject design healthy volunteers will receive either oxytocin or placebo nasal spray (40IU in 10 puffs).

Subjects will come to the experiment in pairs (two friends of the same sex). 45 min after drug administration, the two subjects will simultaneously undergo a social reward task - during the task, functional magnetic resonance imaging (fMRI) data will be acquired from one of them. During the social reward task subjects will be asked to rate the valence and arousal of emotional pictures in three different conditions: alone, share with a stranger and share with their friend.

Before treatment, subjects will complete a range of validated questionnaires to control for potential confounders, such as level of depression (assessed using the BDI) and to explore associations between relevant personality factors and treatment effects, such as adult attachment style (assessed using the AAS).

Enrollment: 252 estimated patients

Sex: All

Ages: 17 to 30 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy subjects without past or current psychiatric or neurological disorder, right-handed, had normal or corrected-to normal vision.

Exclusion criteria

• self-reported medication use, substance abuse, and presence of medical or psychiatric disorders

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

252 participants in 2 patient groups, including a placebo group

Oxytocin

Experimental group

Description:

Oxytoxin nasal spray

Treatment:

Drug: Oxytocin

Placebo

Placebo Comparator group

Description:

Placebo nasal spray

Treatment:

Drug: Placebo